Use of continuous insulin infusion therapy to achieve improved metabolic control.
D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007332:Insulin Infusion Systems / Q000009:adverse effects
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin